Description
The authors posit that as a result of increasing risk aversion and accelerated savings in R&D over the past 3 years, the industry is not developing drugs for increasingly prevalent diseases, untreatable pain, antibiotics and more. The Future of Drug Discovery exposes the disconnect between what society needs and what pharmaceutical companies are working on. Entire drug development programs have been cancelled and incentives are needed for the pharmaceutical industry to change its current research and business path. This thought-provoking book analyzes the situation, projects over 10 years into the future and aids the reader in determining what is needed to ensure that the industry responds to societys needs while remaining commercially attractive.
